ACHC vs. EXAS

Last updated Apr 1, 2026

Compare and contrast key facts about Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS).

Performance

ACHC vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

ACHC vs. EXAS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ACHC Acadia Healthcare Company, Inc.	64.83%	-64.21%	-49.01%	-5.54%	35.62%	20.77%	51.29%	29.21%	-21.21%	-1.42%
EXAS Exact Sciences Corporation	3.30%	80.74%	-24.05%	49.42%	-36.39%	-41.26%	43.26%	46.56%	20.10%	293.26%

Fundamentals

Market Cap ACHC : $2.12B EXAS : $19.91B
EPS ACHC : -$12.19 EXAS : -$1.10
PS Ratio ACHC : 0.64 EXAS : 6.12
PB Ratio ACHC : 1.09 EXAS : 8.29
Total Revenue (TTM) ACHC : $3.31B EXAS : $3.25B
Gross Profit (TTM) ACHC : $1.91B EXAS : $2.26B
EBITDA (TTM) ACHC : -$737.83M EXAS : $42.61M

Returns By Period

In the year-to-date period, ACHC achieves a 64.83% return, which is significantly higher than EXAS's 3.30% return. Over the past 10 years, ACHC has underperformed EXAS with an annualized return of -8.19%, while EXAS has yielded a comparatively higher 32.78% annualized return.

ACHC

• 1D: 2.45%
• 1M: -0.21%
• YTD: 64.83%
• 6M: -5.53%
• 1Y: -22.86%
• 3Y*: -31.34%
• 5Y*: -16.26%
• 10Y*: -8.19%

EXAS

• 1D: 0.00%
• 1M: 1.48%
• YTD: 3.30%
• 6M: 91.76%
• 1Y: 142.34%
• 3Y*: 16.54%
• 5Y*: -3.61%
• 10Y*: 32.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ACHC vs. EXAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACHC

ACHC Risk / Return Rank: 28
ACHC Sharpe Ratio Rank: 26
ACHC Sortino Ratio Rank: 27
ACHC Omega Ratio Rank: 28
ACHC Calmar Ratio Rank: 30
ACHC Martin Ratio Rank: 31

EXAS

EXAS Risk / Return Rank: 96
EXAS Sharpe Ratio Rank: 96
EXAS Sortino Ratio Rank: 98
EXAS Omega Ratio Rank: 97
EXAS Calmar Ratio Rank: 92
EXAS Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACHC vs. EXAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ACHC	EXAS	Difference
Sharpe ratio Return per unit of total volatility	-0.34	2.80	-3.14
Sortino ratio Return per unit of downside risk	-0.10	4.37	-4.46
Omega ratio Gain probability vs. loss probability	0.99	1.64	-0.65
Calmar ratio Return relative to maximum drawdown	-0.36	4.40	-4.76
Martin ratio Return relative to average drawdown	-0.65	15.32	-15.97
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ACHC vs. EXAS - Sharpe Ratio Comparison

The current ACHC Sharpe Ratio is -0.34, which is lower than the EXAS Sharpe Ratio of 2.80. The chart below compares the historical Sharpe Ratios of ACHC and EXAS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ACHC	EXAS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.34	2.80	-3.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.36	-0.07	-0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.17	0.55	-0.72
Sharpe Ratio (All Time) Calculated using the full available price history	-0.00	0.11	-0.12

Correlation

The correlation between ACHC and EXAS is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ACHC vs. EXAS - Dividend Comparison

Neither ACHC nor EXAS has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ACHC vs. EXAS - Drawdown Comparison

The maximum ACHC drawdown since its inception was -98.77%, roughly equal to the maximum EXAS drawdown of -98.01%. Use the drawdown chart below to compare losses from any high point for ACHC and EXAS.

Drawdown Indicators

	ACHC	EXAS	Difference
Max Drawdown Largest peak-to-trough decline	-98.77%	-98.01%	-0.76%
Max Drawdown (1Y) Largest decline over 1 year	-60.98%	-29.56%	-31.42%
Max Drawdown (5Y) Largest decline over 5 years	-86.89%	-78.21%	-8.68%
Max Drawdown (10Y) Largest decline over 10 years	-86.89%	-80.42%	-6.47%
Current Drawdown Current decline from peak	-73.74%	-32.32%	-41.42%
Average Drawdown Average peak-to-trough decline	-56.38%	-49.80%	-6.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.35%	8.48%	+25.87%

Volatility

ACHC vs. EXAS - Volatility Comparison

Acadia Healthcare Company, Inc. (ACHC) has a higher volatility of 14.87% compared to Exact Sciences Corporation (EXAS) at 1.18%. This indicates that ACHC's price experiences larger fluctuations and is considered to be riskier than EXAS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ACHC	EXAS	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.87%	1.18%	+13.69%
Volatility (6M) Calculated over the trailing 6-month period	50.07%	28.31%	+21.76%
Volatility (1Y) Calculated over the trailing 1-year period	66.53%	44.22%	+22.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.98%	54.53%	-9.55%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.28%	59.98%	-11.70%

Financials